Laparoscopic Power Morcellators Market: Hysterectomy Segment Dominated And Accounted For The Largest Revenue Share
Laparoscopic Power Morcellators Industry Overview
The global laparoscopic power morcellators market size is anticipated to reach USD 188.7 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. The increasing number of patients suffering from health issues such as uterine fibroids and endometriosis and the rising number of hysterectomy and myomectomy procedures is expected to drive the demand for laparoscopic power morcellators.
The COVID-19 outbreak has led to the global implementation of strict measures to curb the spread, which has led to a drastic cancellation or halt of elective surgeries including hysterectomy and myomectomy procedures worldwide. During this time, a large number of medical device manufacturing facilities, global suppliers, and distributors have been adversely affected in several regions. However, with the abundance of postponed surgical procedures in the pipeline, the market is expected to rebound and grow significantly over the forecast period.
The prevalence of uterine fibroids in women is on the rise across the globe and this can lead to excessive menstrual bleeding, pelvic pain, infertility, and frequent urination. As per the U.S. National Institutes of Health (NIH), 20-25% of women of reproductive age have fibroids and by the age of 50, up to 80% of black women and up to 70% of white women have fibroids. Thus, the rising prevalence of uterine fibroids is increasing the demand for myomectomy and hysterectomy procedures, thereby contributing to market growth.
Moreover, growing patient preference for minimally invasive treatments is expected to strengthen the growth of the market. Larger fibroids can be removed through minor incisions by breaking them into pieces through a technique called morcellation, with the help of laparoscopic power morcellators. It is a less invasive procedure and causes less discomfort and post-operative pain. This is expected to boost the market growth at a significant rate during the forecast period.
Laparoscopic Power Morcellators Market Segmentation
Grand View Research has segmented the global laparoscopic power morcellators market on the basis of application and region:
Based on the Application Insights, the market is segmented into Hysterectomy, Myomectomy, and Others.
- The hysterectomy segment dominated the market for laparoscopic power morcellators and accounted for the largest revenue share of 70.5% in 2020. The segment is also expected to witness the highest CAGR of 7.7% from 2021 to 2028. This procedure is the most preferred and proven permanent solution for uterine fibroids, thus, contributing to the growth of the segment.
- myomectomyprocedure is considered as standard care for eliminating fibroids and preserving the uterus and provides patients the opportunity to remain fertile. This procedure can preserve fertility, unlike a hysterectomy. There are different ways to perform a myomectomy depending on the size and location of the fibroids. Nowadays, some surgeons are performing single-port (one incision) laparoscopic and robotic myomectomies
Laparoscopic Power Morcellators Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
The key players are stressing on research and development activities to develop technologically advanced products to make morcellators safe. For instance, in May 2018, Intuitive Surgical, a global healthcare company that specializes in minimally invasive and robotic-assisted surgeries, announced the U.S. FDA approval for its “Single Port Platform” - the da Vinci SP Surgical System that utilizes various urologic surgical procedures. This system enables surgeons with robotic-assisted technology intended for deep and narrow access to tissue.
Moreover, major players are adopting various strategies such as new product launches, mergers and acquisitions, and geographic expansion to gain more share in the market for laparoscopic power morcellators. For instance, in October 2019, Ethicon, Inc., and Olympus Corporation have signed an agreement in which Olympus will acquire all new business activities from Ethicon related to the Versapoint Electrosurgery system. Similarly, in May 2020, Minerva Surgical acquired the Intrauterine Health products segment from Boston Scientific Corporation. The products include Symphion Tissue Removal System, Resect Tissue Resection Device, and the Genesys HTA System utilized for the treatment of irregular uterine bleeding and other related disorders. Thus, such developments are expected to significantly influence market growth over the forecast period. Some of the prominent players in the laparoscopic power morcellators market include:
- Medtronic
- Karl Storz GmbH
- Richard Wolf GmbH
- LiNA Medical
- Lumenis (Boston Scientific Corporation)
- Nouvag AG
- Olympus Corporation
- RUDOLF Medical GmbH
Order a free sample PDF of the Laparoscopic Power Morcellators Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment